Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
Abstract Cancer is associated with a high degree of heterogeneity, encompassing both inter- and intra-tumor heterogeneity, along with considerable variability in clinical response to common treatments across patients. Conventional models for tumor research, such as in vitro cell cultures and in vivo...
Main Authors: | Shanqiang Qu, Rongyang Xu, Guozhong Yi, Zhiyong Li, Huayang Zhang, Songtao Qi, Guanglong Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-02-01
|
Series: | Molecular Biomedicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43556-023-00165-9 |
Similar Items
-
Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities
by: Jiani Yang, et al.
Published: (2021-08-01) -
Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
by: Evangelia Sereti, et al.
Published: (2023-03-01) -
Unveiling the potential: Patient-derived organoids in cancer research and treatment
by: Zhan Wang
Published: (2024-03-01) -
Organoids and 3D In Vitro Models as a Platform for Precision Medicine (PM): An Update
by: Payal Ganguly
Published: (2024-08-01) -
Application of Organoids in Lung Cancer Precision Medicine
by: Ziqi JIA, et al.
Published: (2020-07-01)